ARCHIVES

BRCA 1 Mutation Finding Draws Attention To Potential Perils Of Genetic Testing

This article is from The Cancer Letter archive.

Vol. 21 No. 38 | October 6, 1995

Download PDF Visit The Full Archive

Related Articles

FDA Tightens Conflict of Interest Rules For Advisors.

March 23, 2007

Interview: “People don’t understand Clinical Trials.

September 5, 1997

In Brief: Big Ten Cancer Research Consortium Names Executive Officer

May 30, 2014

In Brief: Myers, Whang-Peng, Zink Leaving NCU; FDA Hires New Legislative Affairs Chief

February 18, 1994

In Brief: Bioassay Prime Contract Renewed For Four Years, $34.2 Million; Canellos Quits As Clinical Director

June 20, 1975

Funding opportunities listed.

October 8, 2004